Non-Economic Damages: Intangible Losses and Suffering Non-economic damages address the difficult-to-quantify impacts that Ozempic-related injuries impose on plaintiffs physical well-being, emotional health, and life satisfaction
Both options are available, depending on your state regulations and practice preferences
Each option is reviewed individually, and recommendations depend on provider assessment, patient goals, safety considerations, and medication availability
All authors contributed to the discussion and conclusion and agreed with the current paper
Necrosis of the renal tubules, along with altered fluid balance, can precipitate acute kidney injury and thus impact on pharmacotherapy
Although there is no definitive association of FML with dyslipidemia, statin therapy may be helpful in lowering lipoma size (177) and so a lipid panel is also appropriate